Diseases, Conditions, Syndromes

Tudorza pressair approved for COPD

(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) ...

Diseases, Conditions, Syndromes

UK study highlights importance of spirometry in diagnosing COPD

A UK study of patients participating in low-dose CT lung cancer screening highlights the importance of spirometry (breathing tests) in the assessment of possible chronic obstructive pulmonary disease (COPD), and demonstrates ...

Diseases, Conditions, Syndromes

Emphysema treatment could be optimized using network modelling

A unique engineering perspective of emphysema progression in the lung suggests how mechanisms operating at the micromechanical scale could help to predict patient survival and quality of life following treatment - according ...

Diseases, Conditions, Syndromes

Greater emphysema-like lung on CT linked to mortality

(HealthDay)—For individuals without airflow obstruction or chronic obstructive pulmonary disease (COPD), greater emphysema-like lung on computed tomography (CT) is associated with all-cause mortality, according to a study ...

page 3 from 5